1)Grisanti S, Biester S, Peters S et al:Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 142:158-160, 2006
2)Wakabayashi T, Oshima Y, Sakaguchi H et al:Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571-1580, 2008
3)Takihara Y, Inatani M, Kawaji T et al:Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 20:196-201, 2011
4)Higashide T, Ohkubo S, Sugiyama K:Long-term outcomes and prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma. PLoS One 10:e0135766, 2015
5)Higashide T, Murotani E, Saito Y et al:verse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 250:603-610, 2012
1)Shazly TA, Latina MA:Neovascular glaucoma:etiology, diagnosis and prognosis. Semin Ophthalmol 24:113-121, 2009
2)Kotecha A, Spratt A, Ogunbowale L et al:Intravitreal bevacizumab in refractory neovascular glaucoma:a prospective, observational case series. Arch Ophthalmol 129:145-150, 2011
3)Wakabayashi T, Oshima Y, Sakaguchi H et al:Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571-1580, 80. e1-e3, 2008
4)Hwang HB, Han JW, Yim HB et al:Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma:systematic literature review. J Ocul Pharmacol Ther 31:198-203, 2015
5)Kim M, Lee C, Payne R et al:Angiogenesis in glaucoma filtration surgery and neovascular glaucoma:A review. Surv Ophthalmol 60:524-535, 2015
1)Ishibashi S, Tawara A, Sohma R et al:Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection. Arch Ophthalmol 128:1539-1545, 2010
2)Sugimoto Y, Mochizuki H, Okumichi H et al:Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients. Graefes Arch Clin Exp Ophthalmol 248:1601-1609, 2010